LI
NVO

LHM Inc’s Novo Nordisk NVO Stock Holding History

LHM Inc’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.25M Sell
59,930
-81,557
-58% -$3.86M 0.89% 21
2025
Q4 		$7.2M Hold
141,487
– – 2.68% 12
2025
Q3 		$7.85M Hold
141,487
– – 2.6% 13
2025
Q2 		$9.77M Buy
141,487
+3,036
+2% +$207K 3.24% 7
2025
Q1 		$9.73M Buy
+138,451
New +$11.4M 3.22% 5

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

LHM Inc's NVO Position: Q1 2026 in Review

LHM Inc reduced its Novo Nordisk (NVO) stake by 58% in Q1 2026, selling an estimated $3.86M and leaving 59,930 shares worth $2.25M. The position accounts for 0.89% of the portfolio, ranked #21.

LHM Inc first reported a position in NVO in Q1 2025 and has held it in 5 quarters since. The position peaked at $9.77M in Q2 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • LHM Inc held 59,930 shares of Novo Nordisk worth $2.25M as of Q1 2026.
  • LHM Inc sold 81,557 Novo Nordisk shares in Q1 2026, an estimated $3.86M.
  • Novo Nordisk made up 0.89% of LHM Inc's portfolio in Q1 2026, its #21 holding.
  • LHM Inc first reported a position in Novo Nordisk in Q1 2025 and has held it in 5 quarters since.
  • LHM Inc's Novo Nordisk position peaked at $9.77M in Q2 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on LHM Inc's 13F filing for Q1 2026, filed 14 May 2026.